News Image

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

Provided By GlobeNewswire

Last update: Jul 24, 2025

– Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to diagnose and track disease progression in Multiple System Atrophy –

Read more at globenewswire.com

ALTERITY THERAPEUTICS-ADR

NASDAQ:ATHE (9/19/2025, 8:00:00 PM)

4.48

+0.1 (+2.28%)



Find more stocks in the Stock Screener

Follow ChartMill for more